Analysis shows risk stratification and regulatory T cells may inform immunosuppressive treatments in MDS.
Tregs with an increased risk of disease progression independently of the IPSS-R and the IPSS-M. Our findings suggest that profiling Treg subpopulations at diagnosis could improve MDS risk stratification and guide immunosuppressive therapeutic decisions.
No takes yet. Share an insight, caveat, or question.
Vazquez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: